Author:
Jiang Lulu,Wu Xuefei,Wang Shuo,Chen Shih-Heng,Zhou Hui,Wilson Belinda,Jin Chun-Yang,Lu Ru-Band,Xie Keqin,Wang Qingshan,Hong Jau-Shyong
Funder
National Institute of Environmental Health Sciences
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Neurology,Immunology,General Neuroscience
Reference71 articles.
1. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic—a double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45:789–96.
2. Baldessarini RJ, Frankenburg FR. Drug-therapy—clozapine—a novel antipsychotic agent. New Engl J Med. 1991;324:746–54.
3. Hagger C, Buckley P, Kenny JT, Friedman L, Ubogy D, Meltzer HY. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiatry. 1993;34:702–12.
4. Alvir JMJ, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA. Clozapine-induced agranulocytosis—incidence and risk-factors in the United States. New Engl J Med. 1993;329:162–7.
5. Alvir JM, Lieberman JA. A reevaluation of the clinical characteristics of clozapine-induced agranulocytosis in light of the United States experience. J Clin Psychopharmacol. 1994;14:87–9.
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献